| ID | Sequence | Length | GC content |
|---|---|---|---|
| GAS6-AS1:4 | CUAAGAUGCUAUUUUCAGCAGGUCACUAUAAACGCUUUCUACUCUGAAG… | 3249 nt | 0.5762 |
| GAS6-AS1:5 | CUAAGAUGCUAUUUUCAGCAGGUCACUAUAAACGCUUUCUACUCUGAAG… | 3427 nt | 0.5608 |
| GAS6-AS1:6 | GGCUGUACCUGGGUGCUGUGUCCGCGGGGCGUCUGGAGACGUCGAUGUG… | 1817 nt | 0.6181 |
No relevant information is available at the moment.
A study in human patients identified GAS6-AS1 as a potential biomarker for myocardial fibrosis after acute myocardial infarction, where it may participate in disease development by acting as a competitive endogenous RNA to sponge hsa-miR-135a-5p and thereby regulate CENPB and BCL9L [Wang et al. DOI:10.2147/IJGM.S329391].